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Abstract
Background: In the US, foreign-born Hispanics tend to live in socioeconomic conditions typically associated with
later stage of breast cancer diagnosis, yet they have lower breast cancer mortality rates than their US-born
counterparts. We evaluated the impact of nativity (US- versus foreign-born), neighborhood socioeconomic status
(SES) and Hispanic enclave (neighborhoods with high proportions of Hispanics or Hispanic immigrants) on breast
cancer stage at diagnosis and survival among Hispanics.
Methods: We studied 37,695 Hispanic women diagnosed from 1988 to 2005 with invasive breast cancer from the
California Cancer Registry. Nativity was based on registry data or, if missing, imputed from case Social Security
number. Neighborhood variables were developed from Census data. Stage at diagnosis was analyzed with logistic
regression, and survival, based on vital status determined through 2007, was analyzed with Cox proportional
hazards regression.
Results: Compared to US-born Hispanics, foreign-born Hispanics were more likely to be diagnosed at an advanced
stage of breast cancer (adjusted odds ratio (OR) = 1.14, 95% confidence interval (CI): 1.09-1.20), but they had a
somewhat lower risk of breast cancer specific death (adjusted hazard ratio (HR) = 0.94, 95% CI: 0.90-0.99). Living in
low SES and high enclave neighborhoods was associated with advanced stage of diagnosis, while living in a lower
SES neighborhood, but not Hispanic enclave, was associated with worse survival.
Conclusion: Identifying the modifiable factors that facilitate this survival advantage in Hispanic immigrants could
help to inform specific interventions to improve survival in this growing population.
Background
F o rU n i t e dS t a t e s( U S )H i s p a n i c( a l s ok n o w na sL a t i n a )
women, breast cancer is the most commonly diagnosed
cancer and the leading cause of cancer death [1]. How-
ever, within this population group, breast cancer pat-
terns differ by nativity. Hispanic women who are
foreign-born (representing approximately 40% of this
large and growing minority group [2,3]) have lower
rates of breast cancer incidence [4-6] and mortality [7,8]
than those who are US-born; however, despite these
lower rates, foreign-born Hispanics have a higher likeli-
hood of late stage disease at breast cancer diagnosis and
lower likelihood of receiving guideline-concordant
treatment compared to US-born Hispanics [9]. Further-
more, foreign-born Hispanics also tend to live in Hispa-
nic enclaves (neighborhoods with other Hispanics or
Hispanic immigrants) [10,11], which are generally neigh-
borhoods of lower socioeconomic status (SES) [12], and
SES measured at the county and census tract levels has
been associated with later stage at diagnosis and poorer
survival among Hispanics [12-14].
Similar kinds of mortality differentials have been
described as the “Hispanic paradox,” which refers to
Hispanics having better health outcomes than non-His-
panic Whites despite their generally lower SES and liv-
ing in worse socioeconomic conditions [15,16]. For
breast cancer, the causes of the nativity mortality dif-
ferential are unclear, but may include the selective
immigration of healthy Hispanics [8,17,18], the return
of Hispanics to their native countries after they
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vioral factors [21].
To understand the mortality differences between US
and foreign-born Hispanics, the aims of this study were
to document the breast survival patterns among Hispa-
nics by nativity, and explore whether survival patterns
were influenced by neighborhood factors, using popula-
tion-based cancer registry data enhanced with complete
nativity data and linked to residential data on census
block-group level SES and ethnic enclave. In addition, to
inform the observed patterns and further explore the
role of the Hispanic paradox on breast cancer outcomes,
we examined the prevalence of health care access and
risk factor measures potentially associated with survival
in the female Hispanic population of California, a popu-
lation of primarily Mexican descent [2]. Understanding
the neighborhood influences on outcomes, by nativity,
could help identify subgroups at risk of poor outcomes
as well as factors that contribute to the observed health
advantage in Hispanic immigrants.
Methods
Study population
Cases eligible for the study were all 38,555 Hispanic
female residents of California newly diagnosed with
invasive breast cancer (International Classification of
Diseases–Oncology, 3
rd edition (ICD-O-3) morphology
codes C50.0-50.9) and reported to the California Cancer
Registry (CCR) during the period January 1, 1988
through December 31, 2005. Individual informed con-
sent was not obtained, as the analysis was based on
state-mandated cancer registry data. From this group,
we excluded the 860 women who were diagnosed at
autopsy or by death certificate only, who had zero or
invalid survival time (n = 152), or whose address at
diagnosis could not be precisely geocoded to determine
neighborhood Hispanic enclave (n = 708), resulting in
37,695 cases included in these analyses.
Patient and tumor information
For each breast cancer case, we obtained CCR informa-
tion routinely abstracted from the medical record at
diagnosis [22] on patient age, sex, race/ethnicity, birth-
place, tumor histologic subtype (assigned according to
ICD-O-3 coding as ductal, lobular, or mixed/other),
extent of disease, summary stage (localized, regional/dis-
tant, unknown), and census-block group of residence at
diagnosis. We also obtained registry information on
treatment modality (chemotherapy, radiation, surgery
and hormone therapy) within four months after diagno-
sis, vital status (routinely determined by the CCR
through hospital follow-up and database linkages) as of
December 31, 2007, and, for the deceased, the underly-
ing cause of death.
To classify nativity, we used birthplace information
from the registry (available for 72.3% of cases (65.3%
from hospital medical records and 7.0% from death cer-
tificates)), or by statistical imputation of nativity using
the first five digits of the patient’s Social Security num-
ber (SSN) (for the 25.6% (n = 9,630) of cases for whom
birthplace was unknown). Our previous finding that
cancer cases with unknown registry birthplace differed
from cases with known birthplace with regards to their
age, vital status, and nativity [23,24] showed that exclud-
ing such cases from analyses introduced bias into
results. Because of the joint association of missing birth-
place with birthplace itself and vital status, excluding
cases with missing birthplace in this analysis would bias
the results away from the null [25,26]. To avoid needing
to make this exclusion, we developed and validated a
nativity imputation method using SSNs. Based on the
association of the first five digits of SSNs to the state
and year of issuance [27,28], we imputed immigrant sta-
tus as follows: cases who received their SSN before age
20 were considered US-born, and those who had
received their SSN at or after age 20 were considered
foreign-born. The age cut-point of 20 was determined
from comparison of imputed and self-reported nativity
in previously interviewed cancer patients (N = 1,277)
[24], as well as maximization of predictive value (81%
sensitivity and 80% specificity among US-born) and
minimization of misclassification based on receiver
operating characteristic curves. In addition, 815 cases
(2.2%) had missing or invalid SSNs and were randomly
assigned a nativity based on the age nativity distribution
of the overall sample. We also conducted sensitivity ana-
lyses excluding cases with missing or invalid SSNs and
found that it did not affect our overall results.
Neighborhood socioeconomic status and Hispanic
enclave
We assigned a previously developed neighborhood mea-
sure of SES to cases [29]. The SES measure employed
principal components analysis (PCA) to develop a single
index from seven Census block group indicator variables
(education index, median household income, percent liv-
ing 200% below poverty level, percent blue-collar work-
ers, percent older than 16 in workforce without a job,
median rent, and median house value) [29] from 1990
(for cases diagnosed during 1988-1995) and 2000 (for
cases diagnosed during 1996-2005). This composite
index explained 60% of the variability in the data [29].
To each breast cancer case, we also assigned a neighbor-
hood Hispanic enclave index that was derived, using
PCA [29], from the following Census 1990 or 2000
block group variables: % linguistically isolated, % linguis-
tically isolated who speak Spanish, % speaking limited
English, % Spanish speaking who spoke limited English,
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This composite index explained 68% of the variability in
the data. Each breast cancer patient was assigned a
neighborhood SES and ethnic enclave quintile based on
the distribution of each of these variables across census
block groups in California.
Statistical analysis
Due to high correlations between neighborhood SES and
Hispanic enclave (Spearman rank correlation = 0.70), we
created a four-level combined variable: low SES and low
enclave, low SES and high enclave, high SES and low
enclave, and high SES and high enclave. Low SES was
defined by SES quintiles 1 and 2 and low enclave was
defined by enclave quintiles 1, 2, and 3, based on the
sample size distribution for each variable.
To evaluate the impact of nativity and neighborhood
characteristics on stage of diagnosis (local versus regio-
nal/distant), we used logistic regression to calculate
odds ratios (OR) and associated 95% confidence inter-
vals (CI). Cases missing stage at diagnosis (n = 3,275)
were excluded from these analyses. Models included
nativity, age group and year of diagnosis. Neighborhood
SES and the combined SES-enclave variables were evalu-
ated in separate multivariable models.
To evaluate the impact of nativity and neighborhood
characteristics on overall and breast cancer-specific sur-
vival, we used Cox proportional hazards regression to
calculate hazard ratios (HR) and associated 95% CI’s.
For deceased patients, survival time was measured in
months from the date of diagnosis to the date of death
of any cause for overall survival and to the date of death
from breast cancer for disease-specific survival. For
breast cancer survival, patients who died from other
causes were censored at the time of death. Patients alive
at the study end date (December 31, 2007) were cen-
s o r e da tt h i st i m eo ra td a t eo fl a s tf o l l o w - u p( i . e . ,l a s t
known contact). Among the 25,701 cases alive at last
follow-up, 90.2% had a follow-up date within one year
o ft h es t u d ye n dd a t e ,a n d9 3 . 7 %h a db e e nf o l l o w e d
within two years. Foreign-born women were less likely
to have had complete follow-up within the last two
years (90.7%) than US-born (96.9%).
Multivariable regression models included variables sig-
nificant at p < 0.10 in univariate models or with ap r i o r i
hypotheses for inclusion (e.g., age and stage at diagnosis,
first course of treatment). All variables examined were
included in the multivariable analyses. Effect modifica-
tion between nativity and neighborhood SES or the com-
bined SES/enclave variable was assessed by conducting
stratified analyses and by including interaction terms in
the multivariable models; effect modification was consid-
ered present if the interaction term was significant at p <
0.10. We found no evidence of effect modification for
these variable combinations. In all models, the propor-
tional hazards assumption was assessed by visual inspec-
tion of the survival curves (log (-log) of the survival
distribution function by log (months)); no violations of
the assumption were observed. We did not conduct mul-
tilevel analyses, given minimal spatial clustering of breast
cancer cases in census block groups (n = 16,530 block
groups), as 70.5% of block groups had ≤ 2 cases (45.7%
had only one case). Analyses were conducted using SAS
version 9.1 software (SAS institute Inc., Cary, NC, USA).
Age-adjusted prevalence estimates of selected factors
for the California Hispanic population were obtained
from the 2001 and 2003 California Health Interview
Survey (CHIS) using the internet-based AskCHIS appli-
cation [30]. CHIS data are weighted to the California
Department of Finance estimates of the number of resi-
dents in each California county by age, race and sex,
and the 2000 Census of Population counts from the US
Census Bureau [30]. The institutional review board of
the Cancer Prevention Institute of California approved
this project.
Results
Of the 37,695 eligible Hispanic breast cancer cases, fol-
lowed for a median of 69.9 months, 48.6% were born in
the US (Table 1). Compared to US-born Hispanics, for-
eign-born Hispanics were somewhat more likely to be
diagnosed at a regional or distant stage of disease or with
missing stage information, and to live in the lowest SES
neighborhood and Hispanic enclaves. After adjustment
for age at diagnosis, year of diagnosis and either neigh-
borhood SES (model 1) or the combined neighborhood
SES/enclave variable (model 2) (Table 2), foreign-born
Hispanics remained 14%-15% more likely to be diagnosed
at a regional/distant stage than their US-born counter-
parts. Living in a lower SES neighborhood was associated
with a higher odds of being diagnosed at a regional/dis-
tant stage, with women in the lowest SES neighborhood
3 4 %m o r el i k e l yt ob ed i a g n o s e da tar e g i o n a l / d i s t a n t
stage than women in the highest SES neighborhood
(model 1). Similarly, women from low-SES, high-enclave
neighborhoods (model 2) had a 24% higher odds of being
diagnosed at a regional/distant stage than women from
high-SES, low-enclave neighborhoods.
Foreign-born Hispanics were 5-7% less likely to die
from any cause and from breast cancer than US-born
Hispanics even after consideration of neighborhood
SES (model 1) or the combined neighborhood SES/
enclave variable (model 2) (Table 3). Adding the neigh-
borhood SES or combined neighborhood SES/enclave
variable to these models changed the hazard ratio by
3.6% or less. Lower neighborhood SES was associated
with poorer survival, with Hispanic women in the low-
est SES neighborhoods 31% more likely to die from
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Page 3 of 11Table 1 Characteristics of Hispanic women diagnosed with invasive breast cancer (n = 37,695) by nativity, California,
1988-2005.
Characteristics US-born Hispanics (N = 18,330) Foreign-born Hispanics (N = 19,365)
Case No. (%) Case No. (%) p-value
Age groups
<40 years 2,264 (12.4) 2,545 (13.1)
40-49 years 4,455 (24.3) 5,130 (26.5)
50-59 years 4,358 (23.8) 4,567 (23.6)
60-69 years 3,807 (20.8) 3,569 (18.4)
70+ years 3,446 (18.8) 3,554 (18.4) p < 0.01
Stage at diagnosis
Local 9,884 (53.9) 9,306 (48.1)
Regional 6,335 (34.6) 7,229 (37.3)
Distant 815 (4.5) 851 (4.4)
Missing 1,296 (7.1) 1,979 (10.2) p < 0.01
Histology
Ductal 12,906 (70.4) 13,333 (68.9)
Lobular 1,166 (6.4) 1,051 (5.4)
Mixed/Other 4,258 (23.2) 4,981 (25.7) p < 0.01
Estrogen receptor (ER) status
Positive 8,972 (49.0) 8,649 (44.7)
Negative 3,551 (19.4) 3,822 (19.7)
Other 5,807 (31.7) 6,894 (35.6) p < 0.01
Grade
Grade I 2,313 (12.6) 1,996 (10.3)
Grade II 5,737 (31.3) 5,795 (29.9)
Grade III 6,273 (34.2) 7,237 (37.4)
Grade IV 473 (2.6) 536 (2.8)
Unknown 3,534 (19.3) 3,801 (19.6) p < 0.01
Chemotherapy treatment
Yes 8,093 (44.2) 8,862 (45.8)
No 9,821 (53.6) 9,845 (50.8)
Missing 416 (2.3) 658 (3.4) p < 0.01
Radiation treatment
Yes 7,686 (41.9) 7,323 (37.8)
No 10,643 (58.1) 12,042 (62.2)
Missing 1 (<0.1) 0 (0) p < 0.01
Surgery
Yes 17,421 (95.0) 18,079 (93.4)
No 891 (4.9) 1,268 (6.6)
Missing 18 (0.1) 18 (0.1) p < 0.01
Hormone therapy treatment
Yes 5,461 (29.8) 5,116 (26.4)
No 12,368 (67.5) 13,609 (70.3)
Missing 501 (2.7) 640 (3.3) p < 0.01
Number of lymph nodes
0 9,514 (51.9) 8,800 (45.4)
1-3 3,754 (20.5) 3,910 (20.2)
≥4 2,592 (14.1) 3,261 (16.8)
Missing 2,470 (13.5) 3,394 (17.5) p < 0.01
Tumor size (mm)
≤20 mm 1,601 (8.7) 1,814 (9.4)
>20 mm 16,727 (91.3) 17,544 (90.6)
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cause than women in the highest SES neighborhood
(model 1). When neighborhood SES and Hispanic
enclave were considered together (model 2), Hispanic
women from low-SES neighborhoods had poorer survi-
val, regardless of enclave levels, than women from
high-SES neighborhoods.
CHIS population data (Table 4) indicated that US-
born Hispanics were more likely than foreign-born His-
panics to have graduated from high school and college,
to speak English well, to have a body mass index below
25 kg/m
2, and to have been physically active in the past
3 0d a y s .I na d d i t i o n ,t h e yw e r em o r el i k e l yt oh a v e
undergone mammographic screening, had the same
health insurance for the past year, remained in the US
for medical or dental care, and had someone available
to help with daily chores when sick.
Discussion
In this population-based study of Hispanic women diag-
nosed in California with breast cancer, we found that
a l t h o u g hf o r e i g n - b o r nH i s p a n i c sw e r em o r el i k e l yt ob e
diagnosed at an advanced stage of disease than US-born
Hispanics, they had better survival, even after considera-
tion of stage at diagnosis, initial treatment, demographic,
other tumor characteristics and neighborhood factors,
including SES and ethnic enclave. Our analysis extends
t h ef i n d i n g sf r o mar e c e n ts t u d y[ 9 ]a n ds h o w st h a t
both nativity and neighborhood SES were independently
associated with stage at diagnosis and survival after
breast cancer. We also found that neighborhood SES
was associated with stage at diagnosis, independently
and jointly with ethnic enclave. While residence in
lower SES neighborhoods and ethnic enclaves was asso-
ciated with being diagnosed at an advanced stage of dis-
ease, and lower SES was associated with poorer survival,
the effect of nativity differed between stage at diagnosis
and survival.
In the present study, Hispanics living in low-SES and
high-enclave neighborhoods (comprising 36% of US-
born and 56% of foreign-born Hispanics) were more
likely to be diagnosed with advanced stage breast cancer
Table 1: Characteristics of Hispanic women diagnosed with invasive breast cancer (n = 37,695) by nativity, California,
1988-2005. (Continued)
Missing 2 (<0.1) 7 (<0.1) p = 0.03
Neighborhood SES* (quintiles)
1 (lowest) 4,030 (22.0) 6,971 (36.0)
2 4,266 (23.3) 4,727 (24.4)
3 4,092 (22.3) 3,389 (17.5)
4 3,429 (18.7) 2,465 (12.7)
5 (highest) 2,513 (13.7) 1,813 (9.4) p < 0.01
Hispanic enclave (quintiles)
1 (lowest) 2,080 (11.4) 859 (4.4)
2 3,035 (16.6) 1,796 (9.3)
3 3,786 (20.7) 2,722 (14.1)
4 4,668 (25.5) 4,732 (24.4)
5 (highest) 4,761 (26.0) 9,256 (47.8) p < 0.01
Combined neighborhood SES* and Hispanic enclave**
High SES, low enclave 7,255 (39.6) 4,525 (23.4)
High SES, high enclave 2,779 (15.2) 3,142 (16.2)
Low SES, low enclave 1,646 (9.0) 852 (4.4)
Low SES, high enclave 6,650 (36.3) 10,846 (56.0) p < 0.01
Vital Status
Dead 5,976 (32.6) 6,018 (31.1)
Alive 12,345 (67.4) 13,356 (68.9) p < 0.01
Cause of death (N = 11,994)
Breast cancer 3,464 (58.0) 3,654 (60.7)
Other cancer 528 (8.8) 419 (7.0)
Circulatory disease 938 (15.7) 782 (13.0)
Other causes 882 (14.8) 638 (10.6)
Unknown cause 164 (2.7) 525 (8.7) p < 0.01
*Socioeconomic status
**Low SES includes quintiles 1 and 2; high SES includes quintiles 3, 4 and 5; low enclave includes quintiles 1 and 2; high enclave includes quintiles 3, 4 and 5.
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neighborhoods. Prior studies similarly showed that US
Hispanics living in census tracts with higher percentages
of Hispanics and lower income levels were more likely
to be diagnosed with late stage breast cancer [12], and
that foreign-born Hispanics were more likely than US-
born to be diagnosed at late stage disease [9]. However,
one small study of Hispanics in San Diego county did
not find lower neighborhood income to be associated
with late stage of disease [31]. Having breast cancer
diagnosed at a later stage may stem in part from poorer
health care access and utilization, as previous studies
have found poorer access and utilization among Hispa-
nics who are foreign-born [8,32,33], less acculturated to
the US [34,35] and of lower SES [33,36]. In addition,
foreign-born Hispanic women were less likely to
undergo mammography screening and more likely
to have no usual source of medical care, according to
CHIS data.
Our primary finding of better survival among foreign-
born than US-born Hispanics is consistent with prior
studies of cancer mortality [7,8]. The tendency for for-
eign-born Hispanics to have health that is better than or
comparable to that of non-Hispanic whites [37] and of
US-born Hispanics [7], despite having lower income,
lower education and relatively poorer social or economic
living conditions, has been termed the Hispanic paradox
[15,16]. This paradox could result from a true health
advantage among Hispanics due to more favorable
health behaviors [8] and greater extended family support
[15,21,38], or it could be an artifact of the selective
migration of healthier individuals [8,17]. US-born Hispa-
nics are more likely to be acculturated to US lifestyles,
including engaging in high-risk behavior (e.g., smoking,
drinking, fattier diets), than their foreign-born counter-
parts [8,39], which in turn could influence survival.
Alternatively, the better survival in foreign-born His-
panics could be an artifact of under-ascertainment of
deaths if foreign-born Hispanics return to their native
countries to die [18,40,41]. We found, in 2001 CHIS
data, that a higher percentage of foreign-born Hispanics
left the country for medical/dental care than US-born
Hispanics, and US-born Hispanics had a modestly
shorter time interval between date of last follow-up and
the study end date (average 0.33 years among foreign-
born versus 0.83 years among US-born). However, a
Table 2 Odds ratios* for regional/distant stage of breast cancer diagnosis (versus local) among Hispanic women,
1988-2005, California.
Characteristic Model 1 Model 2
Total No. ** Odds Ratio (95% CI∞) Odds Ratio (95% CI∞)
Nativity
US-born 17,034 Reference Reference
Foreign-born 17,386 1.15 (1.10-1.20) 1.14 (1.09-1.20)
Age at diagnosis
<40 years 4,325 2.34 (2.16-2.53) 2.34 (2.16-2.54)
40-49 years 8,848 1.77 (1.66-1.89) 1.77 (1.65-1.89)
50-59 years 8,188 1.48 (1.38-1.58) 1.47 (1.38-1.58)
60-69 years 6,721 1.14 (1.06-1.23) 1.14 (1.06-1.23)
70+ years 6,338 Reference Reference
Neighborhood SES
± (quintiles)
1 (lowest) 9,755 1.34 (1.24-1.45)
†
2 8,220 1.21 (1.12-1.30)
3 6,928 1.11 (1.03-1.20)
4 5,485 1.08 (0.99-1.17)
5 (highest) 4,032 Reference
Combined neighborhood SES
± and Hispanic enclave
#
High SES, low enclave 11,143
† Reference
High SES, high enclave 5,302 1.08 (1.01-1.15)
Low SES, low enclave 2,414 1.12 (1.03-1.23)
Low SES, high enclave 15,561 1.24 (1.18-1.30)
* Multivariable model adjusted for year of diagnosis and the variables listed in the table.
**There were 3,275 breast cancer cases excluded from stage analysis because they were missing information on stage at diagnosis.
∞Confidence intervals
† Variable not included in model
±Socioeconomic status
# Low SES includes quintiles 1 and 2; high SES includes quintiles 3, 4 and 5; low enclave includes quintiles 1, 2 and 3; high enclave includes quintiles 4 and5 .
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face barriers returning to Cuba, and Puerto Ricans,
whose deaths are recorded in the US national statistics,
did not find evidence that either returning to one’s
native country or the healthy migrant hypothesis
explained the observed mortality paradox [18]. Further-
more, Turra and Elo found that the magnitude of this
migratory bias was too small to explain the mortality
paradox [19].
In the present study, neighborhood SES, but not Hispa-
nic enclave, was associated with survival after breast can-
cer diagnosis. Our findings are supported by previous
studies using SEER data that have found lower census
tract- [13] or county- level [14] poverty levels associated
with poorer 5-year breast cancer-specific survival (1988-
1994) [13] or average annual breast-cancer specific mortal-
ity (1990-2000) [14]; however, these prior studies were
based on SES derived from larger areas, and were not able
to account for nativity. Living in a Hispanic enclave may
be a proxy measure for a low level of acculturation to the
US; studies have shown that Hispanic immigrants tend to
initially reside in segregated enclaves, yet over time and
generations, intermingle with people of other race/ethnici-
ties in the host country [10,11]. Thus, immigrants living in
enclaves may be more likely to maintain advantageous
health behaviors that could impact survival, such as a heal-
thier diet [42,43], if ethnic food sources or other
resources/services in their native language are more read-
ily available. Hispanics may also perceive fewer barriers in
accessing medical care when they live in an area with a
high percentage of Hispanics [44].
Although explanations for SES differences in survival
are not well documented, advanced stage at diagnosis
(often associated with screening behavior) has been the
most cited explanatory factor [45] and there is increasing
evidence of inadequate breast cancer treatment and fol-
low-up care being given to patients in lower SES groups
[45]. These factors, however, have not been found to fully
explain survival disparities associated with SES [38,45].
Furthermore, in the present study, we still observed
neighborhood SES differences when we controlled for
stage at diagnosis and initial course of treatment. SES
inequalities in survival also may be influenced by factors
we could not measure in this study, such as health insur-
ance coverage, quality of treatment and follow-up care,
and co-morbidities [45].
Our study included Hispanic women diagnosed with
invasive breast cancer over an 18-year period in California,
Table 3 Overall and breast cancer-specific survival in Hispanic women, 1988-2005, California.
Characteristic Overall survival* Breast cancer-specific survival*
Model 1 Model 2 Model 1 Model 2
Total No. HR (95% CI∞) HR (95% CI∞) HR (95% CI∞) HR (95% CI∞)
Nativity
US-born 18,330 Reference Reference Reference Reference
Foreign-born 19,365 0.93 (0.90-0.96) 0.93 (0.90-0.97) 0.94 (0.90-0.99) 0.95 (0.90-1.00)
Stage at diagnosis
Local 19,190 Reference Reference Reference Reference
Regional 13,564 2.17 (2.08-2.27) 2.18 (2.08-2.27) 3.35 (3.15-3.56) 3.35 (3.15-3.57)
Distant 1,666 7.98 (7.42-8.58) 7.99 (7.43-8.59) 14.28 (13.05-15.62) 14.30 (13.07-15.64)
Missing 3,275 2.57(2.33-2.83) 2.57 (2.33-2.83) 4.32 (3.83-4.87) 4.33 (3.84-4.88)
Neighborhood SES** (quintiles)
1 (lowest) 11,001 1.42 (1.33-1.52)
† 1.31 (1.20-1.43)
†
2 8,993 1.29 (1.20-1.38) 1.19 (1.09-1.30)
3 7,481 1.20 (1.11-1.28) 1.10 (1.01-1.21)
4 5,894 1.05 (0.98-1.13) 0.99 (0.90-1.09)
5 (highest) 4,326 Reference Reference
Combined neighborhood SES and Hispanic enclave**
††
High SES, low enclave 11,780 Reference Reference
High SES, high enclave 5,921 1.07 (1.01-1.13) 1.03 (0.96-1.11)
Low SES, low enclave 2,498 1.29 (1.19-1.39) 1.24 (1.12-1.37)
Low SES, high enclave 17,496 1.26 (1.21-1.32) 1.22 (1.15-1.29)
* Multivariable model adjusted for age at diagnosis, year of diagnosis, histology (ductal, lobular, mixed/other), ER status (positive, negative, other), grade (I, II, III,
IV, unknown), first course of treatment (chemotherapy, radiation, surgery and hormone therapy) and the variables listed in the table.
**Socioeconomic status (SES). Low SES includes quintiles 1 and 2; high SES includes quintiles 3, 4 and 5; low enclave includes quintiles 1, 2 and 3; high enclave
includes quintiles 4 and 5.
∞Hazard ratios (HR) Confidence intervals (CI)
† Variable not included in model
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Page 7 of 11Table 4 Prevalence of characteristics by nativity in Hispanic women ≥ 18 years, California Health Interview Survey,
2001 and 2003*
Characteristics Nativity**
US-Born % (95% CI†) Foreign-Born % (95% CI†)
Education
Some high school or less 24.0 (21.5-26.5) 67.7 (65.9-69.6)
High school graduate 32.9 (30.6-35.3) 16.2 (14.8-17.7)
Some college 30.5 (28.2-32.8) 11.2 (10.0-12.5)
College graduate or higher 12.6 (11.1-14.1) 4.8 (4.1-5.5)
Marital status
Married 41.4 (39.0-43.8) 56.9 (54.8-59.0)
Live with partner 8.9 (7.3-10.4) 11.7 (10.2-13.3)
Separated/divorced/widowed/other 18.9 (16.9-20.8) 17.3 (15.8-18.9)
Single/never married 30.9 (28.2-33.5) 14.0 (12.4-15.5)
How well speak English
Well/very well 93.8 (92.1-95.5) 25.6 (23.7-27.4)
Not well/not at all 6.2 (4.5-7.9) 74.4 (72.6-76.3)
Body mass index (kg/m
2)
<25 43.8 (41.2-46.4) 37.4 (35.2-39.6)
25-29.99 30.9 (28.5-33.3) 33.6 (31.5-35.8)
≥30 25.3 (23.0-27.5) 29.0 (26.9-31.0)
No vigorous/moderate physical activity in past 30 days 31.9 (29.5-34.3) 59.1 (57.1-61.2)
Mammogram Screening History
2 years or less 55.3 (52.4-58.1) 45.8 (43.5-48.2)
More than 2 years ago 13.0 (11.0-15.1) 11.6 (10.0-13.2)
Never had a mammogram 31.7 ( 29.0-34.3) 42.5 (40.2-44.9)
Type of usual source of medical care (adults)
Doctor’s office/health maintenance organization/Kaiser 71.6 (69.1-74.0) 41.3 (39.3-43.3)
Community clinic/government clinic/community hospital 15.0 (13.1-17.0) 35.3 (33.3-37.3)
Emergency Room/urgent care 1.2 (0.7-1.7) 1.7 (1.1-2.2)
Some other place 0.6 (0.2-1.0) 0.5 (0.2-0.8)
No usual source of care 11.6 (9.7-13.5) 21.2 (19.4-23.0)
Had the same health insurance for the past year 82.2 (80.1-84.3) 78.9 (76.6-81.2)
Went to another country for medical/dental care 3.3 (2.2-4.4) 8.9 (7.7-10.1)
Went to Mexico for other medical care 95.8 (89.9-100) 92.3 (88.4-96.2)
Went to other country for other medical care 4.2 (0.0-10.1) 7.7 (3.8-11.6)
Delayed or didn’t get medical testing/treatment 9.6 (8.2-11.0) 5.3 (4.3-6.2)
Reason delayed or didn’t get medical care
Could not afford/too expensive/no coverage 31.7 (25.7-37.8) 29.3 (23.5-35.0)
Procrastination/inconvenient hours/forgot 38.0 (31.9-44.2) 32.9 (27.2-38.6)
Other 15.9 (11.3-20.6) 14.8 (9.5-20.2)
More than one 14.3 (10.4-18.1) 23.0 (17.7-28.4)
Availability of someone to help with daily chores when sick*
No one available 14.0 (12.3-15.8) 28.6 (26.5-30.8)
Someone available a little/sometimes 30.3 (27.7-32.8) 39.6 (37.2-42.1)
Someone mostly/always available 55.7 (52.9-58.5) 31.7 (29.4-34.0)
* Utilized 2003 California Health Interview Survey data.
** 2001 foreign-born Hispanic estimated sample size was 2,286,000; 2001 US-born Hispanic estimated sample size was 1,276,000. 2003 foreign-born Hispanic
estimated sample size was 2,364,000; 2003 US-born Hispanic estimated sample size was 1,519,000.
†Confidence intervals
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Page 8 of 11which means that our findings are generalizable to a larger
Hispanic population of primarily Mexican descent (which
represents 77% of California’s Hispanic population [2]).
Another benefit of our use of population-based data is the
uniformly collected survival time for all patients, which
minimized bias due to differential follow-up. We also used
a measure of neighborhood SES that previously has
demonstrated SES gradients in incidence and survival of
breast cancer [29,46].
Our analysis did not include clinical prognostic informa-
tion, as it is not routinely collected in cancer registry data,
and although we considered the types of cancer-directed
treatment received within four months of diagnosis, we
did not have details on treatment such as chemotherapy
components and regimen, or treatment received after this
period; therefore, our nativity and neighborhood findings
could be subject to residual confounding from incomplete
treatment data in the cancer registry [47]. We also lacked
information about treatment failure or recurrence.
Furthermore, our study did not have individual-level mea-
sures of SES or acculturation to consider separately or
with our neighborhood measures. While neighborhood
and individual SES are associated, neighborhood SES has
been found to underestimate associations observed with
individual-level SES [48].
Our imputation of nativity, although an improvement
over prior methods [49], is subject to some error; how-
ever, given similar sensitivity and positive predictive
value rates in the method, it is likely that misclassifica-
tion as foreign-born balanced misclassification as US-
born. The impact on case counts within groups defined
by nativity is likely small, given that nativity was
imputed for about one-quarter of cancer patients, and
that prior research has found high accuracy for cancer
registry birthplace data [23,24,50]. Our data on Hispanic
race/ethnicity may also be subject to misclassification,
although several studies have shown cancer registry clas-
sification of Hispanic race/ethnicity to be good (~80%
sensitivity and positive predictive values) [50,51]. Also,
we improved the identification of Hispanics by using the
North American Association of Central Cancer Regis-
tries Hispanic Identification Algorithm in this study
[52]; in a recent study of breast cancer patients in Los
Angeles, Hispanic classification using this algorithm had
97.7% sensitivity and 90.7% specificity compared to self-
report [53]. Although Hispanics are heterogeneous with
regard to country of origin, we were not able to con-
sider outcomes by this variable because it was not avail-
able for 57.5% Hispanics in our study. Lastly, breast
cancer-specific survival analyses are subject to the inac-
curacy of the underlying cause of death code, which pre-
viously has been found to be between 84% and 90%
accurate [54,55].
Conclusions
Despite the tendency for later stage at diagnosis of breast
cancer and greater likelihood of living in lower SES
neighborhoods and Hispanic enclaves, foreign-born His-
panics had better survival after breast cancer than US-
born Hispanics, consistent with the Hispanic paradox.
Further research is needed to examine the reasons for
the observed paradox, as identifying factors that facilitate
this survival advantage in Hispanic immigrants could
improve survival for all women with breast cancer.
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